We are live on ! Find out more
TF

Talbot Financial Portfolio holdings

AUM $1.36B
1-Year Est. Return 31.29%
This Fund
S&P 500
This Quarter Est. Return
+6.11%
1 Year Est. Return
+31.29%
3 Year Est. Return
+99.91%
5 Year Est. Return
10 Year Est. Return
AUM
$775M
AUM Growth
+$27.3M
Cap. Flow
-$20.2M
Cap. Flow %
-2.6%
Top 10 Hldgs %
51.08%
Holding
62
New
2
Increased
28
Reduced
21
Closed
4

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$673K
2
MDT icon
Medtronic
MDT
+$658K
3
CRM icon
Salesforce
CRM
+$566K
4
JNJ icon
Johnson & Johnson
JNJ
+$467K
5
BMY icon
Bristol-Myers Squibb
BMY
+$446K

Top Sells

Rank Stock Value
1
TRV icon
Travelers Companies
TRV
+$14.2M
2
GPN icon
Global Payments
GPN
+$6.71M
3
MSFT icon
Microsoft
MSFT
+$1.46M
4
AMAT icon
Applied Materials
AMAT
+$766K
5
AMZN icon
Amazon
AMZN
+$699K

Sector Composition

Rank Sector Weight
1 Technology 42.7%
2 Healthcare 16.14%
3 Financials 13.47%
4 Consumer Discretionary 9.1%
5 Communication Services 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.81T
$91M 11.74%
203,503
-3,451
-2% -$1.46M
AAPL icon
2
Apple
AAPL
$4.67T
$79.6M 10.28%
378,110
-2,613
-0.7% -$487K
AMZN icon
3
Amazon
AMZN
$2.87T
$50.4M 6.51%
261,047
-3,806
-1% -$699K
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.19T
$33.7M 4.35%
183,860
-2,500
-1% -$425K
AMAT icon
5
Applied Materials
AMAT
$366B
$29.9M 3.85%
126,543
-3,570
-3% -$766K
NVDA icon
6
NVIDIA
NVDA
$5.25T
$27.7M 3.58%
224,492
+6,652
+3% +$673K
ADBE icon
7
Adobe
ADBE
$116B
$24.7M 3.19%
44,453
-98
-0.2% -$47.5K
INTU icon
8
Intuit
INTU
$97.9B
$21.9M 2.83%
33,353
+159
+0.5% +$98.6K
JPM icon
9
JPMorgan Chase
JPM
$951B
$18.9M 2.44%
93,587
+661
+0.7% +$129K
GS icon
10
Goldman Sachs
GS
$301B
$17.8M 2.3%
39,408
+154
+0.4% +$67.6K
CVX icon
11
Chevron
CVX
$396B
$16.4M 2.12%
104,823
-167
-0.2% -$26.6K
COST icon
12
Costco
COST
$419B
$16.2M 2.09%
19,090
-94
-0.5% -$73.4K
CRM icon
13
Salesforce
CRM
$211B
$15.8M 2.04%
61,607
+2,116
+4% +$566K
ABBV icon
14
AbbVie
ABBV
$451B
$15.6M 2.01%
90,662
+1,168
+1% +$193K
LLY icon
15
Eli Lilly
LLY
$1.05T
$14.7M 1.9%
16,288
+362
+2% +$290K
SYK icon
16
Stryker
SYK
$127B
$14.7M 1.9%
43,157
-70
-0.2% -$23.7K
V icon
17
Visa
V
$712B
$14M 1.81%
53,509
-463
-0.9% -$127K
JNJ icon
18
Johnson & Johnson
JNJ
$646B
$13.8M 1.78%
94,601
+3,142
+3% +$467K
HD icon
19
Home Depot
HD
$329B
$13.2M 1.7%
38,250
-211
-0.5% -$72K
SNPS icon
20
Synopsys
SNPS
$84.8B
$13.1M 1.69%
21,985
+325
+2% +$184K
CB icon
21
Chubb
CB
$131B
$13M 1.68%
51,153
+700
+1% +$180K
TVTX icon
22
Travere Therapeutics
TVTX
$6.19B
$12.9M 1.67%
+63,546
New +$428K
HON icon
23
Honeywell
HON
$68.9B
$12.5M 1.61%
61,952
+724
+1% +$138K
AMGN icon
24
Amgen
AMGN
$234B
$12.1M 1.57%
38,872
-72
-0.2% -$21.2K
SCHW
25
Charles Schwab
SCHW
$191B
$11.3M 1.46%
153,734
+845
+0.6% +$62.4K

Similar funds

Talbot Financial's Q2 2024 Portfolio in Review

As of Q2 2024, Talbot Financial held 62 positions worth $775M, up 3.7% from $747M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Talbot Financial's Q2 2024 filing shows 2 new, 28 increased, 21 reduced and 4 closed positions. Its largest new stake was Travere Therapeutics: 63,546 shares worth $12.9M. The largest sale was Travelers Companies, an estimated $14.2M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 40% a quarter earlier, followed by Healthcare and Financials.

  • Talbot Financial's largest Q2 2024 buy was Travere Therapeutics: 63,546 shares worth $12.9M.
  • Talbot Financial added most to NVIDIA in Q2 2024, an estimated $673K increase.
  • Talbot Financial's biggest Q2 2024 reduction was Microsoft, cutting an estimated $1.46M.
  • Talbot Financial fully exited Travelers Companies in Q2 2024, selling an estimated $14.2M.
  • Talbot Financial's ten largest holdings make up 51% of its $775M portfolio in Q2 2024.
  • Talbot Financial opened 2 new positions and closed 4 in Q2 2024.
  • Talbot Financial's portfolio value rose 3.7% quarter-over-quarter to $775M.

Based on Talbot Financial's 13F filing for Q2 2024, filed 11 Jul 2024.